News
Consumers who bought a popular cough syrup could be eligible for money ... million to resolve claims it advertised the product as “non-drowsy” despite containing an ingredient that could ...
Robitussin was at the center of a class-action complaint over its “non-drowsy” cough and cold medicines. Screengrab from Calchi, et al. v. GlaxoSmithKline Consumer Healthcare Holdings (US ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results